Abstract: This study investigates the impact of heat waves on conductor ampacity and temperature in Malaysia, which are influenced by climate change. Rising ambient temperatures result in decreased ...

The introduction of enfortumab vedotin combined with pembrolizumab (EV-P) as a first-line treatment for advanced urothelial carcinoma (UC) has transformed the therapeutic landscape and holds great ...

Thomas P.M. Barnett is senior business strategist at Throughline Inc. and the author of America’s New Map. Find his daily newsletter at thomaspmbarnett.substack.com. After two world wars nearly ...

MASSILLON – The annual Beat McKinley parade is slated to kickoff at 7 p.m. Oct. 24 in downtown. The event, which runs until approximately 9 p.m., starts along Lincoln Way E at Eighth Street NE, ...

SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, announced the first reported median overall survival ...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY ® (datopotamab deruxtecan-dlnk) demonstrated a statistically significant and clinically ...

Daiichi Sankyo and AstraZeneca’s DATROWAY also demonstrated a highly statistically significant and clinically meaningful 43% reduction in patients’ risk of disease progression or death DATROWAY is the ...

(UroToday.com) The 2025 ESMO annual meeting featured a kidney cancer mini oral session and a presentation by Dr. Zhenhua Liu discussing results from the FRUSICA-2 trial assessing fruquintinib + ...

A regulatory decision is expected during the first quarter of 2026. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for ...

As the U.S. fiscal year begins, the Department of State has released the November 2025 Visa Bulletin, outlining the latest updates for immigrant visa availability and adjustment of status (AOS) filing ...